Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Alterations of Innate and Adaptive Immune Cells During the Course of SARS CoV-2 Pneumonia

NCT04816760 is registered in ClinicalTrials.gov with Institut Hospitalo-Universitaire Méditerranée Infection as lead sponsor.

NCT NCT04816760
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04816760 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Alterations of Innate and Adaptive Immune Cells During the Course of SARS CoV-2 Pneumonia
Lead sponsor
Institut Hospitalo-Universitaire Méditerranée Infection
Phase
Observational
Overall status
Unknown status
Start date
March 25, 2020
Completion date
December 31, 2021
Enrollment
100 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

alveolar lung disease, endothelial dysfunction, immunization; infection, innate immunity, sars-cov2